REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharma Patent Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Real Estate
Full name: PHARMA PATENT Kereskedelmi Tanacsado es Szolgaltato Kft. Profile Updated: January 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Hungarian Download a sample report

Pharma Patent Kft. is a company based in Hungary, with its head office in Szentendre. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. Pharma Patent Kft. was incorporated on September 23, 1998. Pharma Patent Kft. currently employs 16 (2023) people. From the latest financial highlights, Pharma Patent Kft. reported a net sales revenue increase of 6.04% in 2021. Its’ total assets recorded a negative growth of 5.28%. Pharma Patent Kft.’s net profit margin decreased by 8.16% in 2021.

Headquarters
Szentlaszloi ut 44.
Szentendre; Pest; Postal Code: 2000

Contact Details: Purchase the Pharma Patent Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Patent Kft. report to view the information.
Outstanding Shares:
Purchase the Pharma Patent Kft. report to view the information.
Registered Capital:
Purchase the Pharma Patent Kft. report to view the information.
Financial Auditors:
Purchase the Pharma Patent Kft. report to view the information.
Incorporation Date:
September 23, 1998
Key Executives
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Pernix Pharma Kft.
Company Performance
Financial values in the chart are available after Pharma Patent Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
6.04%
Total operating revenue
2.81%
Operating profit (EBIT)
35.85%
EBITDA
31.53%
Net Profit (Loss) for the Period
-39.32%
Total assets
-5.28%
Total equity
16.93%
Operating Profit Margin (ROS)
5.79%
Net Profit Margin
-8.16%
Return on Equity (ROE)
-13.42%
Debt to Equity Ratio
-29.32%
Quick Ratio
0.06%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?